A study to show the effect Of Vitamin D Supplementation On Serum Methylglyoxal in Diabetic Retinopathy patients
Phase 2
- Conditions
- Health Condition 1: E103- Type 1 diabetes mellitus with ophthalmic complicationsHealth Condition 2: E113- Type 2 diabetes mellitus with ophthalmic complications
- Registration Number
- CTRI/2024/04/065762
- Lead Sponsor
- Institute of the ophthalmology, JNMC, AM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with Non Proliferative and Proliferative Diabetic Retinopathy
Exclusion Criteria
i. Patients receiving vitamin D and calcium supplements.
ii. Patients taking any other medication that could change vitamin D metabolism, such as Rifampicin or Phenytoin.
iii. Patients with very low vitamin D / sufficient vitamin levels.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum levels of methylglyoxal after vitamin D supplementationTimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method serum methylglyoxal in various grades of diabetic retinopathyTimepoint: 12 weeks